DLBCL: CAR-T-Zell-Therapie mit hoher Ansprechrate
Crossref DOI link: https://doi.org/10.1007/s15004-020-8046-z
Published Online: 2020-04-20
Published Print: 2020-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Onkologie, Redaktion
Text and Data Mining valid from 2020-04-01
Version of Record valid from 2020-04-01
Article History
First Online: 20 April 2020